Venture capitalists and other investors in biotech discuss the ins and outs of investing.
ChinaBio® Partnering Forum 2017: HitGen aids China drug discovery with DNA library
Wei Chen, head of R&D for Chengdu-based HitGen describes to Scrip’s Brian Yang how the Chinese startup partners with multinationals to speed up new drug development in China, and planned IND filing fo
Download "Finding Finance" Industry ReportClick Here
Where are they now? EpiAxis Therapeutics channels successes into scientific and business development
EpiAxis Therapeutics is channeling its success at BioPharm America™’s Startup Day into success at the business and scientific levels. Since finishing first for best “investment pitch quality and...
ChinaBio® Partnering Forum 2017: Funding drug development in China through VCs and partnerships
Western and China companies are leveraging the significant funding and support available in China to develop their assets more cost effectively and efficiently. 2016 set another record in VC funds rai
ChinaBio® Partnering Forum 2017: Rapid change: Good times for pharma?
Everything in China seems to be on the fast track. This is especially true in the pharma industry, where new announcements affecting regulations, pricing, and reimbursement are occurring on nearly a d
Biotech Startups: Land and conduct a successful investor meeting
Biotech startup companies face many challenges, but one of the most common is landing and conducting meetings with potential investors. The following are pieces of advice from investors on what...
Where are they now? Cocoon Biotech planning tox studies
Recognition from a high profile organization like the BioPharm America™ conference has been tremendous for Cocoon,” Ailis Tweed-Kent, MD, founder and CEO of Cocoon Biotech says. Winning the...
Where are they now? For Virvio, it’s all about visibility
When Virvio participated in BioPharm America™’s Startup Day pitch contest in 2016, the company had been operational less than one year. It had three employees and was operating under grants from...
How can startup companies get noticed by potential investors and partners?
Access the industry's premier life science partnering event, BioPharm America™ in Boston September 26–27, 2017, to connect with strategic partners and get your innovation funded. No other event combin
The Digital Medicine Crystal Ball
How will digital technologies impact disease management and healthcare over the next decade? Find out in the just-released whitepaper, “The Digital Medicine Crystal Ball: Unlocking the Future of...
Where to start: How to gain a foothold in the China biopharmaceutical market
The China pharmaceutical market has come of age. With record breaking investments in innovative companies, support from the CFDA, and new product approvals pending, China has entered a new age as...
BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets
With the Latin American vaccines market forecast to more than quadruple in size from just over USD 150 million to 2015 to just under USD 700 million in 2020, opportunities abound for both homegrown bu
BIO-Europe Spring® 2017: Infant Bacterial Therapeutics harnesses microbiome to treat preterm babies
By harvesting Lactobacillus reuteri from lactating mothers, Infant Bacterial Therapeutics has developed an approach to treat necrotizing enterocolitis, a major killer of premature babies. Company CEO
BIO-Europe Spring® 2017: Seventure Partners predicts bright future for microbiome opportunities
Seventure Partners’ Eric de la Fortelle explains to Informa Pharma Intelligence’s Mike Ward how the venture capitalist’s EUR 160 million fund will prosper from the increased understanding of human and
Testimonials highlight opportunities for China cross-border collaboration
ChinaBio® Partnering Forum 2017 meets May 31–June 1 in Zhuhai, China. Don’t miss the abundant opportunities to engage with the global life science community and forge valuable cross-border partnership
Health tech innovators pitch business ideas to expert panel at BIO-Europe Spring®
The buzz steadily grew as the Health Tech Competition got underway on the last day of BIO-Europe Spring® March 22 in Barcelona. As delegates filed into the competition room, the energy was...
Report findings provide insight into technological innovations and trends in drug development
Knect365 Life Sciences has released a report offering unique insights into the awareness, perceptions and implementation of technological innovations in the drug development industry. Based on a...
BIO-Europe Spring® 2017: Noxxon CEO discusses partners and cancer combinations
Noxxon CEO Aram Mangasarian talks to Scrip about development plans for the company's lead compound NOX-A12, which is being tested as a combination therapy for a number of cancer indications. NOX-A12 i
BIO-Europe Spring® 2017: Celyad VP talks IP issues, development timelines for CAR-T therapies
Georges Rawadi, VP of business development and intellectual property at Celyad, discusses the company's CAR-T pipeline, recently resolved IP issues and the firm's strategy for future clinical developm
BIO-Europe Spring® 2017: Sofinnova chairman discusses entrepreneurial culture change in biotech
Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, th
Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III
Li Chen, PhD, co-founded Hua Medicine (Shanghai) six years ago with Ge Li, PhD, founder of WuXi AppTec. The company soon in-licensed global rights to a GKA treatment for type 2 diabetes from...